Nitrosonifedipine, a Photodegradation Product of Nifedipine, Suppresses Pharmacologically Induced Aortic Aneurysm Formation
Conclusion: NO-NIF has the potential to be a new, nifedipine-derived therapeutic drug for suppressing aortic aneurysm formation by directly improving aortic structure with its strong ability to reduce oxidative stress and inflammation.Pharmacology 2018;102:287 –299
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Antidoxidants | Aortic Aneurysm | Cardiology | Cardiovascular | Drugs & Pharmacology | Genetics | Heart | Nifedipine | Study